BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32355273)

  • 1. Comprehensive analysis of the SLC16A gene family in pancreatic cancer via integrated bioinformatics.
    Yu S; Wu Y; Li C; Qu Z; Lou G; Guo X; Ji J; Li N; Guo M; Zhang M; Lei L; Tai S
    Sci Rep; 2020 Apr; 10(1):7315. PubMed ID: 32355273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Expression and Survival Significance of Glucose Transporter-1 in Pancreatic Cancer: Meta-Analysis, Bioinformatics Analysis and Retrospective Study.
    Du J; Gu J; Deng J; Kong L; Guo Y; Jin C; Bao Y; Fu D; Li J
    Cancer Invest; 2021 Oct; 39(9):741-755. PubMed ID: 34229540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer.
    Yang ZQ; Liu YJ; Zhou XL
    Med Sci Monit; 2020 Apr; 26():e921769. PubMed ID: 32235821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.
    Zhang R; Zhang LJ; Yang ML; Huang LS; Chen G; Feng ZB
    Mol Med Rep; 2018 Feb; 17(2):2211-2228. PubMed ID: 29207133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of the GATA transcription factor gene family in breast carcinoma using gene microarrays, online databases and integrated bioinformatics.
    Yu S; Jiang X; Li J; Li C; Guo M; Ye F; Zhang M; Jiao Y; Guo B
    Sci Rep; 2019 Mar; 9(1):4467. PubMed ID: 30872657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Cell-Surface Marker SLC16A1 Shortened Survival in Human High-Grade Gliomas.
    Lin HH; Tsai WC; Tsai CK; Chen SH; Huang LC; Hueng DY; Hung KC
    J Mol Neurosci; 2021 Aug; 71(8):1614-1621. PubMed ID: 33641091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
    Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
    EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
    Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic value of
    Wang MQ; Yin QY; Chen YR; Zhu SL
    Future Oncol; 2021 Dec; 17(35):4907-4923. PubMed ID: 34751593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
    Li X; Tian R; Gao H; Yang Y; Williams BRG; Gantier MP; McMillan NAJ; Xu D; Hu Y; Gao Y
    Sci Rep; 2017 Nov; 7(1):16495. PubMed ID: 29184082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of Immunoinhibitors Identifies LGALS9 and TGFBR1 as Potential Prognostic Biomarkers for Pancreatic Cancer.
    Fan Y; Li T; Xu L; Kuang T
    Comput Math Methods Med; 2020; 2020():6138039. PubMed ID: 33062039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
    Yi L; Luo P; Zhang J
    J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancer.
    Ma X; Tao R; Li L; Chen H; Liu Z; Bai J; Shuai X; Wu C; Tao K
    Oncol Rep; 2019 Jan; 41(1):292-300. PubMed ID: 30365134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and supervised learning methods.
    Li C; Zeng X; Yu H; Gu Y; Zhang W
    World J Surg Oncol; 2018 Nov; 16(1):223. PubMed ID: 30428899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
    Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
    Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
    Li H; Liu JW; Liu S; Yuan Y; Sun LP
    Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets.
    Liu L; Wang S; Cen C; Peng S; Chen Y; Li X; Diao N; Li Q; Ma L; Han P
    Mol Med Rep; 2019 Aug; 20(2):1901-1914. PubMed ID: 31257501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.